Prognostic Circulating Cytokine Panels for Metronomic Chemotherapy in Metastatic Gastrointestinal Cancer: Exploratory Pharmacodynamic Biomarker Analysis of the Phase II COMET Trial.
Simple Summary: Metronomic chemotherapy—a regimen based on continuous low doses of anticancer drugs—represents a valuable treatment option for patients with advanced gastrointestinal cancers who have already received multiple lines of therapy. However, identifying in advance which patients are most...
| Publicado en: | Cancers Vol. 18; no. 11; pp. 1762 - 1780 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
MDPI
Jun2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |